Back to Search
Start Over
GlycoMimetics: NCI Phase 2/3 study of uproleselan did not meet primary endpoint
- Source :
- The Fly. October 29, 2024
- Publication Year :
- 2024
-
Abstract
- GlycoMimetics announced the Phase 2 analysis of the adaptive Phase 2/3 study of uproleselan being conducted by the National Cancer Institute and the Alliance for Clinical Trials in Oncology in [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.814066608